We are live on ! Find out more
AC

Ayrton Capital Portfolio holdings

AUM $14.7M
1-Year Est. Return 12.82%
This Fund
S&P 500
This Quarter Est. Return
-0.41%
1 Year Est. Return
-12.82%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$61.6M
AUM Growth
-$15.4M
Cap. Flow
+$3.92M
Cap. Flow %
6.36%
Top 10 Hldgs %
54.05%
Holding
131
New
17
Increased
Reduced
1
Closed
11

Sector Composition

Rank Sector Weight
1 Financials 54.38%
2 Healthcare 11.73%
3 Technology 10.01%
4 Consumer Discretionary 3.86%
5 Communication Services 2.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MEOA
26
DELISTED
Minority Equality Opportunities Acquisition Inc. Class A Common Stock
MEOA
$709K 1.15%
70,000
BSGA
27
DELISTED
Blue Safari Group Acquisition Corp. Class A Ordinary Share
BSGA
$708K 1.15%
70,000
RICO
28
DELISTED
Agrico Acquisition Corp
RICO
$668K 1.09%
50,000
WARR
29
DELISTED
Warrior Technologies Acquisition Company
WARR
$654K 1.06%
65,802
BRLS icon
30
Borealis Foods
BRLS
$16.7M
$601K 0.98%
60,000
SOC icon
31
Sable Offshore Corp
SOC
$991M
$548K 0.89%
55,929
POL.WS
32
DELISTED
Polished.com Inc. Warrants to Purchase Common Stock
POL.WS
$520K 0.84%
2,000,000
MOBX icon
33
Mobix Labs
MOBX
$25.2M
$499K 0.81%
5,000
GCTS
34
GCT Semiconductor Holding
GCTS
$174M
$497K 0.81%
50,000
MTC icon
35
MMTec
MTC
$389M
$435K 0.71%
18,453
RCHG
36
DELISTED
Recharge Acquisition Corp. Class A Common Stock
RCHG
$420K 0.68%
42,000
EUDA icon
37
EUDA Health Holdings
EUDA
$57.8M
$395K 0.64%
2,000
TWLV
38
DELISTED
Twelve Seas Investment Company II Class A Common Stock
TWLV
$389K 0.63%
39,767
GGGV
39
DELISTED
G3 VRM Acquisition Corp. Class A Common Stock
GGGV
$347K 0.56%
34,200
PMCB icon
40
PharmaCyte Biotech
PMCB
$6.25M
$343K 0.56%
153,130
BRTX icon
41
BioRestorative Therapies
BRTX
$5.2M
$181K 0.29%
61,418
-16,344
-21% -$69.3K
PEPL
42
DELISTED
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
$129K 0.21%
13,028
ABTC
43
American Bitcoin Corp
ABTC
$399M
$124K 0.2%
+30
New +$515K
SKYAW
44
SkyAI Inc
SKYAW
$263K
$65K 0.11%
+235,200
New +$97.1K
UNCY icon
45
Unicycive Therapeutics
UNCY
$138M
$64K 0.1%
7,665
SWAGW icon
46
Stran & Company Warrant
SWAGW
$60K 0.1%
224,260
SURGW
47
DELISTED
SurgePays, Inc. Warrant
SURGW
$60K 0.1%
50,000
NBEV
48
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$53K 0.09%
234,387
EZRAW
49
DELISTED
Reliance Global Series A Warrants
EZRAW
$37K 0.06%
97,818
SBEV.WS
50
DELISTED
Splash Beverage Group, Inc. Warrants to purchase 1/40th of a share of Common Stock at an exercise price of $184.00
SBEV.WS
$36K 0.06%
49,800

Similar funds

Ayrton Capital's Q2 2022 Portfolio in Review

As of Q2 2022, Ayrton Capital held 131 positions worth $61.6M, down 20% from $76.9M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Ayrton Capital deployed $3.92M of net new capital in Q2 2022, opening 17 new positions. Its largest new stake was SHF Holdings: 59,019 shares worth $12.5M.

By sector, the portfolio is most concentrated in Financials at 54% of assets, up from 24% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was BioRestorative Therapies, an estimated $69.3K trimmed.

  • Ayrton Capital's largest Q2 2022 buy was SHF Holdings: 59,019 shares worth $12.5M.
  • Ayrton Capital's biggest Q2 2022 reduction was BioRestorative Therapies, cutting an estimated $69.3K.
  • Ayrton Capital fully exited OTR Acquisition Corp. Class A Common Stock in Q2 2022, selling an estimated $2.04M.
  • Ayrton Capital's ten largest holdings make up 54% of its $61.6M portfolio in Q2 2022.
  • Ayrton Capital opened 17 new positions and closed 11 in Q2 2022.
  • Ayrton Capital's portfolio value fell 20% quarter-over-quarter to $61.6M.

Based on Ayrton Capital's 13F filing for Q2 2022, filed 15 Aug 2022.